Treatment Action Group (TAG) and the Stop TB Partnership released the report called Tuberculosis Research Funding Trends, 2005–2021.
For the first time in history, funding for tuberculosis (TB) research and development (R&D) hit a billion dollars worldwide in 2021.
But, this funding for TB R&D is a mere fraction of what’s needed to achieve the United Nations’ sustainable development goal of ending TB as a pandemic by 2030.
Every day, 4,400 people continue to die from TB, a treatable and curable airborne infectious disease.
The United Nations High-Level Meeting on TB in 2018 set the target of $2 billion per annum for R&D.
The Stop TB Partnership’s ‘Global Plan to End TB, 2023–2030’ estimates the funding need for TB R&D to have gone up to $5 billion per annum.